BullFrog AI Holdings has announced a partnership agreement with Eleison Pharmaceuticals to apply its artificial intelligence (AI) solutions to Eleison’s pivotal Phase III trial of pancreatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback